Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Landon L Chan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Biochemistry|May 14, 2015
Bioinformatics analysis of circulating cell-free DNA sequencing dataLandon L Chan, Peiyong Jiang
Therapeutic Advances in Medical Oncology|March 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Expert Opinion on Emerging Drugs|March 16, 2021
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinomaLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|May 25, 2023
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatmentLandon L Chan, Stephen L Chan
Cancers|March 25, 2022
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaLandon L Chan, Stephen L Chan
Current Oncology (Toronto, Ont.)|August 25, 2022
Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and BeyondMaple Ye Feng, Landon L Chan, Stephen Lam Chan
Hepatic Oncology|October 30, 2025
Clinical management of liver cancer patients with immune checkpoint inhibitors treatmentJohnny C W Yau, Landon L Chan, Stephen L Chan
Journal of Gastroenterology and Hepatology|March 26, 2026
Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard-of-Care and Emerging Therapeutic StrategiesLandon L Chan, Kallista O K Chan, Stephen L Chan
Annals of Hepatology|February 10, 2025
Treatment for hepatocellular carcinoma after immunotherapyLandon L Chan, Tsz Tung Kwong, Johnny C W Yau, et al.
The Journal of Liquid Biopsy|March 3, 2025
Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectivesMolly S C Li, Kevin K S Mok, Landon L Chan, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Biochemistry|May 14, 2015
Bioinformatics analysis of circulating cell-free DNA sequencing dataLandon L Chan, Peiyong Jiang
Therapeutic Advances in Medical Oncology|March 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Expert Opinion on Emerging Drugs|March 16, 2021
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinomaLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|May 25, 2023
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatmentLandon L Chan, Stephen L Chan
Cancers|March 25, 2022
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaLandon L Chan, Stephen L Chan
Current Oncology (Toronto, Ont.)|August 25, 2022
Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and BeyondMaple Ye Feng, Landon L Chan, Stephen Lam Chan
Hepatic Oncology|October 30, 2025
Clinical management of liver cancer patients with immune checkpoint inhibitors treatmentJohnny C W Yau, Landon L Chan, Stephen L Chan
Journal of Gastroenterology and Hepatology|March 26, 2026
Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard-of-Care and Emerging Therapeutic StrategiesLandon L Chan, Kallista O K Chan, Stephen L Chan
Annals of Hepatology|February 10, 2025
Treatment for hepatocellular carcinoma after immunotherapyLandon L Chan, Tsz Tung Kwong, Johnny C W Yau, et al.
The Journal of Liquid Biopsy|March 3, 2025
Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectivesMolly S C Li, Kevin K S Mok, Landon L Chan, et al.
Pageof 3